FIELD: biotechnology, medicine, proteins.
SUBSTANCE: invention describes new polypeptide in isolated form relating to subfamily of superfamily human immunoglobulins (Ig-Sf). This polypeptide shows at least 70% of homology level with amino acid sequence of murine molecules CRAM-1 or CRAM-2 regulated by the confluence of adhesive (figures 3, 6 are represented in the claim). Also, invention relates to antibodies showing specificity with respect to the polypeptide. Antibodies and soluble polypeptide can be used for treatment of inflammation and tumors. Invention describes polynucleotide or oligonucleotide encoding the full-size polypeptide or its moiety and represents primer, probe, anti-sense RNA and shows the nucleotide sequence that is identical conceptually with human CRAM-1. Invention provides preparing new adhesive proteins from superfamily Ig-Sf that are regulated at the transcription level in endothelium by effect of tumors. Invention can be used for treatment of different diseases, in particular, inflammatory responses.
EFFECT: valuable medicinal properties of polypeptide.
19 cl, 33 dwg, 1 ex
Title |
Year |
Author |
Number |
VASCULAR ADHESION PROTEIN-1 OF AMINOOXIDASE ACTIVITY |
1998 |
- Jalkanen Sirpa
- Salmi Marko
- Smit Dehjvid Dzhon
- Bono Petri
|
RU2204838C2 |
NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR |
2002 |
|
RU2316591C2 |
ISOLATED NUCLEIC ACID MOLECULE ENCODING CHIMERIC TIE-2-LIGAND (VARIANTS), CHIMERIC OR MODIFIED TIE-2-LIGAND AND METHOD FOR ITS PREPARING, VECTOR, METHOD FOR PREPARING SYSTEM VECTOR-HOST, CONJUGATE, PHARMACEUTICAL COMPOSITION |
1997 |
- Dehvis Sehmjuel'
- Jankopoulos Dzhordzh D.
|
RU2233880C2 |
VIRAL VECTOR MANUFACTURE |
2014 |
|
RU2658487C2 |
MODIFIED ANTAGONISTIC ANTIBODY |
2001 |
- Fukusima Naosi
- Tsutija Masajuki
- Uno Sinsuke
- Okhtomo Tosikhiko
- Jabuta Naokhiro
- Tsunoda Khirojuki
|
RU2295537C2 |
APPLICATION OF FUSED POLYPEPTIDE CONTAINING MeCP2 PROTEIN AND PROTEIN TRANSDUCTION DOMAIN, PHARMACEUTICAL COMPOSITION CONTAINING SUCH PROTEIN AND METHOD OF TREATING AND/OR PREVENTING DEVELOPMENTARY NEUROPATHY |
2006 |
|
RU2432359C2 |
LINE OF CELLS CHO[V3D], SECRETING RECOMBINANT VESSEL ENDOTHELIUM GROWTH FACTOR (VEGF) OF HUMANS, ISOFORM A165, WITH EXOGENIC 3×DED-EPITOPE |
2012 |
- Vikhreva Polina Nikitichna
- Lysjuk Elena Jur'Evna
- Lukashina Marina Igorevna
- Gnuchev Nikolaj Vasil'Evich
- Larin Sergej Sergeevich
- Korobko Elena Vladimirovna
- Korobko Igor' Viktorovich
|
RU2493251C1 |
DEGRADED ANTIBODY AS TPO AGONIST |
2001 |
- Tsutija Masajuki
- Okhtomo Tosikhiko
- Jabuta Naokhiro
- Tsunoda Khirojuki
- Orita Tetsuro
|
RU2287534C2 |
DPPIV-COGNATED NEW SERINE PROTEASE GENE |
2001 |
- Ki Stiv
- Akinsan'Ja Karen O.
- Riv'Er P'Er Zh.-M.
- Zhjun'En Zhan-Lui
|
RU2305133C2 |
PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALIN XCD3, EPCAMXCD3, IGF-1RXCD3 OR FAP-ALPHA XCD3 BISPECIFIC SINGLE-CHAIN ANTIBODY WITH INTER-SPECIES SPECIFICITY |
2009 |
- Kufer,Peter
- Raum,Tobias
- Kischel,Roman
- Lutterbuse,Ralf
- Hoffmann,Patrick
- Rau,Doris
- Klinger,Matthias
- Mangold,Susanne
- Blumel,Claudia
|
RU2547600C2 |